Xiaoli Ma
Impact in
- Neurology top 5%
- Neuroblastoma Research and Treatments
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 35
- Neuroblastoma Research and Treatments 35
- Co-authors
- Wen Zhao (18 shared papers)Zhixia Yue (14 shared papers)Mei Jin (11 shared papers)Yan Su (22 shared papers)Chao Duan (25 shared papers)Pengfei Tu (1 shared paper)Qian Yu (1 shared paper)Yong Jiang (1 shared paper)
- Journals
- Medicine (4 papers)Pediatric Blood & Cancer (4 papers)Blood (3 papers)Translational Pediatrics (3 papers)Annals of Oncology (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoli Ma
109 papers receiving 902 citations
Peers
Comparison fields: 5 of 109
- Neurology 213
- Cancer Research 121
- Oncology 171
- Immunology 97
- Genetics 42
Countries citing papers authored by Xiaoli Ma
This map shows the geographic impact of Xiaoli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Ma more than expected).
Fields of papers citing papers by Xiaoli Ma
This network shows the impact of papers produced by Xiaoli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Ma. The network helps show where Xiaoli Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 86 | |
| 2 | Use of virtual reality (immersive vs. non immersive) for pain management in children and adults: A systematic review of evidence from randomized controlled trials | 2012 | 53 |
| 3 | 2014 | 41 | |
| 4 | 2018 | 37 | |
| 5 | 2020 | 26 | |
| 6 | 2017 | 26 | |
| 7 | 2019 | 25 | |
| 8 | 2018 | 24 | |
| 9 | Clinical characteristics and prognosis of childhood rhabdomyosarcoma: a ten-year retrospective multicenter study. | 2015 | 23 |
| 10 | 2020 | 19 | |
| 11 | 2020 | 19 | |
| 12 | 2019 | 18 | |
| 13 | 2016 | 17 | |
| 14 | 2017 | 17 | |
| 15 | 2017 | 17 | |
| 16 | 2017 | 16 | |
| 17 | 2017 | 15 | |
| 18 | 2012 | 15 | |
| 19 | 2019 | 15 | |
| 20 | 2020 | 15 |
About Xiaoli Ma
Xiaoli Ma is a scholar working on Neurology, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 116 papers that have together received 909 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (35 papers), Acute Lymphoblastic Leukemia research (9 papers), Congenital Diaphragmatic Hernia Studies (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Sarcoma Diagnosis and Treatment (6 papers), CAR-T cell therapy research (6 papers), Lung Cancer Research Studies (5 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Neurology (213 citations), Cancer Research (121 citations), Oncology (171 citations), Immunology (97 citations) and Genetics (42 citations). Xiaoli Ma has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wen Zhao, Zhixia Yue, Mei Jin, Yan Su, Chao Duan, Pengfei Tu, Qian Yu, Yong Jiang, Ke‐Wu Zeng and Huanmin Wang. Their work appears in journals such as Medicine, Pediatric Blood & Cancer, Blood, Translational Pediatrics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.